| __timestamp | Merck & Co., Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 79838000 |
| Thursday, January 1, 2015 | 6704000000 | 121816000 |
| Friday, January 1, 2016 | 7194000000 | 117633000 |
| Sunday, January 1, 2017 | 9982000000 | 117456000 |
| Monday, January 1, 2018 | 9752000000 | 171984000 |
| Tuesday, January 1, 2019 | 9872000000 | 257452000 |
| Wednesday, January 1, 2020 | 13397000000 | 477643000 |
| Friday, January 1, 2021 | 12245000000 | 540684000 |
| Saturday, January 1, 2022 | 13548000000 | 651496000 |
| Sunday, January 1, 2023 | 30531000000 | 666563000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceutical innovation, research and development (R&D) budgets are a critical indicator of a company's commitment to future growth. Over the past decade, Merck & Co., Inc. and PTC Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking at an impressive $30.5 billion in 2023. This reflects Merck's aggressive pursuit of groundbreaking therapies and its robust pipeline. In contrast, PTC Therapeutics, a smaller player, increased its R&D spending by approximately 735% during the same period, reaching $666 million in 2023. This growth underscores PTC's dedication to niche markets and innovative solutions.
These figures highlight the diverse approaches within the pharmaceutical industry, where both giants and emerging companies play pivotal roles in shaping the future of healthcare.
Comparing Innovation Spending: Merck & Co., Inc. and Bristol-Myers Squibb Company
R&D Insights: How Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc. Allocate Funds
Merck & Co., Inc. vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Wave Life Sciences Ltd.
Comparing Innovation Spending: Merck & Co., Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and PTC Therapeutics, Inc.
Incyte Corporation vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Summit Therapeutics Inc. and PTC Therapeutics, Inc. Allocate Funds
R&D Insights: How Exelixis, Inc. and PTC Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and PTC Therapeutics, Inc.
CRISPR Therapeutics AG or PTC Therapeutics, Inc.: Who Invests More in Innovation?